12:00 AM
Nov 01, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Foradil formoterol fumarate: Began Phase II testing

SkyePharma plc (LSE:SKP; SKYE), London, U.K.
Novartis Pharma AG, Basel, Switzerland
Product: Foradil formoterol fumarate...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >